Exp Dermatol (2019) 28:52835
Progressive Dosing Schedule and Weight Loss Timeline After the initial 0.25 mg phase, doses increase by 0.25 mg increments every 4 weeks: 0.25 mg (weeks 14), 0.5 mg (weeks 58), 0.75 mg (weeks 912), and 1.0 mg (weeks 1316)
BG has received fees for the activities of speaking, scientific advising, or clinical research from Eli Lilly, Novo Nordisk, AstraZeneca, Sanofi, Bristol Myers Squibb, Novartis, GlaxoSmithKline, Johnson & Johnson, Bayer, Intercept Pharma France, Gilead, Boehringer Ingelheim, Janssen, Intarcia, MetaCure, Pfizer, Merck Sharp & Dohme, Roche Diagnostics, Medtronic, Insulet, A
--- This content was translated from Spanish to English using artificial intelligence and was reviewed by an editor before being published
Stable gastric pentadecapeptide BPC 157, Robert's stomach cytoprotection/adaptive cytoprotection/organoprotection, and Selye's stress coping response: progress, achievements, and the future